Forteo (teriparatide)

Manufacturer:

Lilly

Route of Administration:

Subcutaneous

Site of Care:

Outpatient

Website:

Manufacturer Website

phone:

Enrollment Forms:

Synergen Prescription Form

Patient Support Form

Approved Indication:

treatment of postmeopausal women with osteoporosis at high risk for fracture or patients who have failed or are intolerant to over available osteoporosis therapyy
increase of bone mass in men with primary or hypogonadal osteoporosis at high risk for fracture or patients who have failed or are intolerant to other available osteoporosis therapy
treatment of men and women with osteoporosis associated with sustained systemic glucocorticoid therapy at high risk for fracture or patients who have failed or are intolerant to other available osteoporosis therapy

Conditions:

Osteoporosis